The Economics of Pain

The Economics of Pain

Regulation, Product Liability, and the Opioid Crisis

von John E. Schneider

Product liability cases aimed at opioids have featured inflated damages and abatement costs, and responsibility for those costs has fallen on recognizable targets rather than true causal factors. Most opioid cases have ended in settlements, but such endings offer little in the way of closure to a problem that overwhelmed regulators and befuddled the entire medical profession. Courts were left to pick up the pieces, but the tools and data they were provided were woefully incomplete, with claimants incurring opioid-related costs but overstating future needs, and defendants unsure how to assess the impact of harms that they argued were too distant from their products—products that were used properly by the vast majority of users.  This book synthesizes the information available following these court cases and breaks down the story of the opioid crisis from an economic perspective, rooted in the concepts of externalities, regulation, and organizational economics. Chapters analyze what happened, where things went wrong, and how we can work to reconfigure infrastructure that enabled the opioid crisis. 

Applying logical frameworks to often-reactionary systems, the book provides insight into product liability, epidemiology, the economics of externalities, regulatory failure, and alternative forms of governance. The resulting book helps readers confront the hardest-hitting questions, including: How could a crisis like this occur in one of the most regulated sectors of the economy? Will the lessons learned from the litigation prevent a situation like this from happening again? 

“Economist John E. Schneider applies economic theory to the epidemic and ensuing litigation, exposing how regulatory breakdowns and institutional incentives fueled the crisis. Drawing on expert witness experience, Schneider challenges prevailing narratives and reframes how we understand — and address — complex public health failures.“ (Michael Vinluan, MD, JD, FCLM, Past President, American College of Legal Medicine)

“Economist John E. Schneider applies economic theory to the epidemic and ensuing litigation, exposing how regulatory breakdowns and institutional incentives fueled the crisis. Drawing on expert witness experience, Schneider challenges prevailing narratives and reframes how we understand—and address—complex public health failures.”—Michael Vinluan, MD, JD, FCLM, Past President, American College of Legal Medicine

Product liability cases aimed at opioids have featured inflated damages and abatement costs, and responsibility for those costs has fallen on recognizable targets rather than true causal factors. Most opioid cases have ended in settlements, but such endings offer little in the way of closure to a problem that overwhelmed regulators and befuddled the entire medical profession. Courts were left to pick up the pieces, but the tools and data they were provided were woefully incomplete, with claimants incurring opioid-related costs but overstating future needs, and defendants unsure how to assess the impact of harms that they argued were too distant from their products—products that were used properly by the vast majority of users.  This book synthesizes the information available following these court cases and breaks down the story of the opioid crisis from an economic perspective, rooted in the concepts of externalities, regulation, and organizational economics. Chapters analyze what happened, where things went wrong, and how we can work to reconfigure infrastructure that enabled the opioid crisis. 

Applying logical frameworks to often-reactionary systems, the book provides insight into product liability, epidemiology, the economics of externalities, regulatory failure, and alternative forms of governance. The resulting book helps readers confront the hardest-hitting questions, including: How could a crisis like this occur in one of the most regulated sectors of the economy? Will the lessons learned from the litigation prevent a situation like this from happening again? 

John E. Schneider is the co-founder and CEO of Avalon Health Economics LLC (AHE), a health economics consultancy focused on data-driven business analytics, health economics and outcomes research, litigation support, and policy analysis. He holds a BA and MA in economics from the University of Maine, and he earned a PhD in health economics from University of California, Berkeley.

Highlights

• Analyzes the economics of the opioid crisis Provides insight on product liability, externalities, public nuisance, and economic rationale Highlights means to identify causal factors for product liability in complex supply chains and public context

Über den Autor

John E. Schneider is the co-founder and CEO of Avalon Health Economics LLC (AHE), a health economics consultancy focused on data-driven business analytics, health economics and outcomes research, litigation support, and policy analysis. He holds a BA and MA in economics from the University of Maine, and he earned a PhD in health economics from University of California, Berkeley.